Literature DB >> 3522916

Pathogenesis and management of arthropathy in cystic fibrosis.

B M Phillips, T J David.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3522916      PMCID： PMC1290127     

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  47 in total

1.  Pulmonary osteoarthropathy. Association with mesenchymal tumor metastases to the lungs.

Authors:  J J Lokich
Journal:  JAMA       Date:  1977-07-04       Impact factor: 56.272

2.  Arthritis and skin lesions resembling erythema nodosum in pancreatic disease.

Authors:  G T Mullin; E M Caperton; S R Crespin; R C Williams
Journal:  Ann Intern Med       Date:  1968-01       Impact factor: 25.391

Review 3.  Digital clubbing and hypertrophic osteoarthropathy: The underlying mechanisms.

Authors:  J M Shneerson
Journal:  Br J Dis Chest       Date:  1981-04

4.  Role of immune complexes in hypertrophic osteoarthropathy and nonmetastatic polyarthritis.

Authors:  M S Awerbuch; P M Brooks
Journal:  Ann Rheum Dis       Date:  1981-10       Impact factor: 19.103

5.  Antibacterial precipitins and autoantibodies in serum of patients with cystic fibrosis.

Authors:  N Høiby; A Wiik
Journal:  Scand J Respir Dis       Date:  1975-05

6.  Arthritis associated with jejunoileal bypass: clinical and immunologic evaluation.

Authors:  M Zapanta; M Aldo-Benson; A Biegel; J Madura
Journal:  Arthritis Rheum       Date:  1979-07

7.  Cystic fibrosis in adolescents and young adults.

Authors:  A D Howie; B H Stack
Journal:  Scott Med J       Date:  1979-07       Impact factor: 0.729

8.  [Chronic polyarthritis in cystic fibrosis].

Authors:  L De Lumley; R Umdenstock; J Boulesteix; C Labrousse; G Simon
Journal:  Arch Fr Pediatr       Date:  1983-11

9.  Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.

Authors:  R W Pitcher-Wilmott; R J Levinsky; D J Matthew
Journal:  Arch Dis Child       Date:  1982-08       Impact factor: 3.791

10.  Cystic fibrosis: a new outlook. 70 patients above 25 years of age.

Authors:  H Shwachman; M Kowalski; K T Khaw
Journal:  Medicine (Baltimore)       Date:  1977-03       Impact factor: 1.889
View more
  13 in total

Review 1.  Joint disorders in cystic fibrosis.

Authors:  M A Turner; E Baildam; L Patel; T J David
Journal:  J R Soc Med       Date:  1997       Impact factor: 5.344

2.  Rheumatoid factors in cystic fibrosis: associations with disease manifestations and recurrent bacterial infections.

Authors:  M Coffey; J Hassan; C Feighery; M Fitzgerald; B Bresnihan
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

3.  The case for cystic fibrosis centres.

Authors:  T J David
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

Review 4.  The difficulties of treating cystic fibrosis in adults.

Authors:  A K Webb
Journal:  J R Soc Med       Date:  1987       Impact factor: 5.344

5.  Arthropathy in a patient with cystic fibrosis taking ciprofloxacin.

Authors:  M Alfaham; M E Holt; M C Goodchild
Journal:  Br Med J (Clin Res Ed)       Date:  1987-09-19

6.  The arthropathy of cystic fibrosis.

Authors:  J Dixey; A N Redington; R C Butler; M J Smith; J R Batchelor; D F Woodrow; M E Hodson; J C Batten; D A Brewerton
Journal:  Ann Rheum Dis       Date:  1988-03       Impact factor: 19.103

Review 7.  Use of the quinolones in paediatrics.

Authors:  U B Schaad
Journal:  Drugs       Date:  1993       Impact factor: 9.546

Review 8.  Safety of ciprofloxacin in children: worldwide clinical experience based on compassionate use. Emphasis on joint evaluation.

Authors:  V Chyský; K Kapila; R Hullmann; G Arcieri; P Schacht; R Echols
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

Review 9.  Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal.

Authors:  M LeBel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

Review 10.  Safety and efficacy of ciprofloxacin in paediatric patients--review.

Authors:  R Kubin
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.